Filing Details
- Accession Number:
- 0001144204-14-009870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 16:31:01
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 16:31:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Medgenics Inc. | MDGN | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516544 | Andrew Pearlman | C/O Medgenics, Inc. 435 Devon Park Drive Bldg 700 Wayne PA 19087 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-12 | 11,168 | $3.14 | 51,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-12 | 11,168 | $9.00 | 40,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option Award (right to buy) | Disposition | 2014-02-12 | 11,168 | $0.00 | 11,168 | $3.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,632 | 2014-09-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 94 | Indirect | By Spouse |
| Common Stock | 1,719 | Indirect | By ADP Holdings LLC |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2013.
- The option award became fully exercisable on September 13, 2013 in accordance with the terms of the reporting person's separation agreement entered into upon his resignation as the issuer's President and Chief Executive Officer.
Billionaire Hedge Funds
